Extended Data Fig. 3: Tumour evolutionary trees in STSs and LTSs of PDAC.
From: Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
(a, b) Tumour clone phylogenies in primary and recurrent PDACs from STSs (a, n = 6) and LTSs (b, n = 9).
